Humans are the only host of Bordetella pertussis. It is highly contagious, with rates of transmission of up to 80% among susceptible close contacts.[2]Kilgore PE, Salim AM, Zervos MJ, et al. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016 Jul;29(3):449-86.
https://journals.asm.org/doi/10.1128/CMR.00083-15
http://www.ncbi.nlm.nih.gov/pubmed/27029594?tool=bestpractice.com
Prior to the advent of an effective vaccine in the 1940s, pertussis was one of the most common childhood infections, occurring predominantly in the summer and autumn, and in epidemics every 2-5 years. With the introduction of whole-cell pertussis vaccine in the US, reported cases of pertussis fell from 150 per 100,000 people to 1 per 100,000 people in the 1980s.[2]Kilgore PE, Salim AM, Zervos MJ, et al. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016 Jul;29(3):449-86.
https://journals.asm.org/doi/10.1128/CMR.00083-15
http://www.ncbi.nlm.nih.gov/pubmed/27029594?tool=bestpractice.com
[4]Cherry JD. The 112-year odyssey of pertussis and pertussis vaccines - mistakes made and implications for the future. J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):334-41.
https://academic.oup.com/jpids/article/8/4/334/5359449
http://www.ncbi.nlm.nih.gov/pubmed/30793754?tool=bestpractice.com
[5]Centers for Disease Control and Prevention. Pertussis cases by year (1922-2021). Aug 2022 [internet publication].
https://www.cdc.gov/pertussis/php/surveillance/pertussis-cases-by-year.html?CDC_AAref_Val=https://www.cdc.gov/pertussis/surv-reporting/cases-by-year.html
Beginning in the 1990s, and coincident with a switch from whole-cell to acellular pertussis vaccines that was prompted by adverse events associated with whole-cell vaccine, the incidence of pertussis has increased, particularly in adolescents and adults. This increase is not completely understood. Contributing factors may include the more rapid waning of immunity following immunization with acellular pertussis vaccines, decreasing vaccination rates, changes in the pathogenicity of circulating strains of B pertussis, a greater awareness of the disease, and the increasing use of more sensitive nucleic acid amplification-based diagnostic tests.[4]Cherry JD. The 112-year odyssey of pertussis and pertussis vaccines - mistakes made and implications for the future. J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):334-41.
https://academic.oup.com/jpids/article/8/4/334/5359449
http://www.ncbi.nlm.nih.gov/pubmed/30793754?tool=bestpractice.com
[6]Cherry JD. Epidemic pertussis and acellular pertussis vaccine failure in the 21st century. Pediatrics. 2015 Jun;135(6):1130-2.
http://www.ncbi.nlm.nih.gov/pubmed/25941310?tool=bestpractice.com
[7]McGirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics. 2015 Feb;135(2):331-43.
http://www.ncbi.nlm.nih.gov/pubmed/25560446?tool=bestpractice.com
It is likely that large numbers of pertussis cases are not diagnosed and the true public health burden of the disease, therefore, is underestimated. Pertussis is endemic worldwide.[3]Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - pertussis/whooping cough. May 2023 [internet publication].
https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/pertussis-whooping-cough
Globally, it continues to be a major cause of morbidity and mortality, especially in underimmunized populations.[4]Cherry JD. The 112-year odyssey of pertussis and pertussis vaccines - mistakes made and implications for the future. J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):334-41.
https://academic.oup.com/jpids/article/8/4/334/5359449
http://www.ncbi.nlm.nih.gov/pubmed/30793754?tool=bestpractice.com
Models suggest that in 2014 there were 24.1 million global cases of pertussis and 160,700 deaths in children ages <5 years, with the highest proportion of infections and deaths in the WHO African region.[8]Yeung KHT, Duclos P, Nelson EAS, et al. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017 Sep;17(9):974-80.
http://www.ncbi.nlm.nih.gov/pubmed/28623146?tool=bestpractice.com
In the US, a decrease in pertussis incidence in infants ages <2 months has been observed following the introduction of the maternal tetanus-diphtheria-acellular pertussis (Tdap) vaccine, suggesting that maternal Tdap vaccination may be associated with a reduction in pertussis burden in this age group.[9]Skoff TH, Deng L, Bozio CH, et al. US infant pertussis incidence trends before and after implementation of the maternal tetanus, diphtheria, and pertussis vaccine. JAMA Pediatr. 2023 Apr 1;177(4):395-400.
http://www.ncbi.nlm.nih.gov/pubmed/36745442?tool=bestpractice.com